The Effects of Super-Flux (High Performance) Dialyzer on Plasma Glycosylated Pro-B-Type Natriuretic Peptide (proBNP) and Glycosylated N-Terminal proBNP in End-Stage Renal Disease Patients on Dialysis

• Yasuaki Nakagawa,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Toshio Nishikimi ,

  * E-mail: nishikim@kuhp.kyoto-u.ac.jp

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Koichiro Kuwahara,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Shinji Yasuno,

  Affiliation Department of EBM Research, Kyoto University Hospital, Institute for Advancement of Clinical and Translational Science, Kyoto, Japan

  ⨯
• Hideyuki Kinoshita,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Yoshihiro Kuwabara,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Kazuhiro Nakao,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Takeya Minami,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Chinatsu Yamada,

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• Kenji Ueshima,

  Affiliation Department of EBM Research, Kyoto University Hospital, Institute for Advancement of Clinical and Translational Science, Kyoto, Japan

  ⨯
• Yoshihiro Ikeda,

  Affiliation Medical corporation, Ikeda Clinic, Kyoto, Japan

  ⨯
• Hiroyuki Okamoto,

  Affiliation Diagnostics Division, Shionogi & Co., Ltd, Oska, Japan

  ⨯
• Kazukiyo Horii,

  Affiliation Diagnostics Division, Shionogi & Co., Ltd, Oska, Japan

  ⨯
• Kiyoshi Nagata,

  Affiliation Diagnostics Division, Shionogi & Co., Ltd, Oska, Japan

  ⨯
• Kenji Kangawa,

  Affiliation Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Fujishirodai, Suita, Osaka, Japan

  ⨯
• Naoto Minamino,

  Affiliation Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Fujishirodai, Suita, Osaka, Japan

  ⨯
•  [ ... ],
• Kazuwa Nakao

  Affiliation Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan

  ⨯
• [ view all ]
• [ view less ]